Literature DB >> 23739161

Resistant hypertension-complex mix of secondary causes and comorbidities.

T Dudenbostel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23739161      PMCID： PMC3836905          DOI： 10.1038/jhh.2013.46

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  18 in total

1.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

2.  Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.

Authors:  Carolina C Gonzaga; Krishna K Gaddam; Mustafa I Ahmed; Eduardo Pimenta; S Justin Thomas; Susan M Harding; Suzanne Oparil; Stacey S Cofield; David A Calhoun
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

3.  Obstructive sleep apnea and aldosterone.

Authors:  Anna Svatikova; Lyle J Olson; Robert Wolk; Bradley G Phillips; Taro Adachi; Gary L Schwartz; Virend K Somers
Journal:  Sleep       Date:  2009-12       Impact factor: 5.849

4.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Franco Veglio; Chiara Bertello; Nicoletta Sonino; Paolo Della Mea; Mario Ermani; Franco Rabbia; Giovanni Federspil; Paolo Mulatero
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

5.  The role of aldosteronism in causing obesity-related cardiovascular risk.

Authors:  David A Calhoun; Kumar Sharma
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

6.  Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

Authors:  Alejandro de la Sierra; Julián Segura; José R Banegas; Manuel Gorostidi; Juan J de la Cruz; Pedro Armario; Anna Oliveras; Luis M Ruilope
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

7.  Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women.

Authors:  T L Goodfriend; D E Kelley; B H Goodpaster; S J Winters
Journal:  Obes Res       Date:  1999-07

8.  Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.

Authors:  Gian Paolo Rossi; Anna Belfiore; Giampaolo Bernini; Bruno Fabris; Graziella Caridi; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Massimo Mannelli; Gaetana Palumbo; Anna Patalano; Damiano Rizzoni; Ermanno Rossi; Achille C Pessina; Franco Mantero
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

9.  The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients.

Authors:  M L Tuck; J Sowers; L Dornfeld; G Kledzik; M Maxwell
Journal:  N Engl J Med       Date:  1981-04-16       Impact factor: 91.245

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.